Skip to main content
OpenTrials

Clinical trial condition

Recurrence

Explore clinical trials studying Recurrence. Study availability and eligibility vary by location and protocol.

2,359 public trials 538 recruiting studies
Refine in advanced search Browse all conditions

Recurrence trial results

Recruiting

A Study of Codrituzumab in Children and Young Adults With Solid Tumors and Have Not Responded to Treatment or Have Come Back After Treatment

NCT04928677

Conditions
Disease Attributes, Hepatoblastoma, Neoplasms, +8 more
Locations
  • Children's Hospital of Los Angeles (Data Collection Only) Los Angeles, California, United States
  • Children's Healthcare of Atlanta (Data Collection Only) Atlanta, Georgia, United States
  • Dana Farber Cancer Institute (Data Collection Only) Boston, Massachusetts, United States
  • Memorial Sloan Kettering Cancer Center New York, United States
View Trial Details
Recruiting

First-in-human Study of a New Treatment (4A10) for Patients With Relapsed or Hard-to-treat Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma, Focused on Safety and How the Drug Behaves in the Body and Early Signs of Effect.

NCT07586618

Conditions
Acute Lymphoblastic Leukemia ALL, Disease Attributes, Hematologic Diseases, +14 more
Locations
  • Children's Hospital Colorado Aurora, Colorado, United States
  • Children's Hospital of Philadelphia Philadelphia, Pennsylvania, United States
  • Cook Children's Medical Center Fort Worth, Texas, United States
  • Texas Children's Hospital Houston, Texas, United States
View Trial Details
Recruiting

IMA402 T Cell-Engaging Receptor Molecule (TCER®) in Recurrent and/or Refractory Solid Tumors

NCT05958121

Conditions
Cancer, Disease Attributes, Neoplasms, +6 more
Locations
  • Universitaetsklinikum Heidelberg AöR Heidelberg, Baden-Wurttemberg, Germany
  • Thoraxklinik Heidelberg gGmbH Heidelberg, Baden-Wurttemberg, Germany
  • Universitaetsklinikum Mannheim GmbH Mannheim, Baden-Wurttemberg, Germany
  • Universitaetsklinikum Tuebingen AöR Tübingen, Baden-Wurttemberg, Germany
View all 29 locations
View Trial Details
Recruiting

A Phase I/II Study of AZD4512 Monotherapy or in Combination With Anticancer Agents in Participants With Relapsed/Refractory B-cell Non-Hodgkin Lymphoma

NCT07123454

Conditions
B-Cell Non-Hodgkin Lymphoma, Disease Attributes, Hemic and Lymphatic Diseases, +12 more
Locations
  • Research Site Irvine, California, United States
  • Research Site Jacksonville, Florida, United States
  • Research Site Rochester, Minnesota, United States
  • Research Site New York, United States
View all 23 locations
View Trial Details
Recruiting

A Study of JNJ-79635322 in Participants With Relapsed or Refractory Multiple Myeloma or Previously Treated Amyloid Light-chain (AL) Amyloidosis

NCT05652335

Conditions
Amyloidosis, Blood Protein Disorders, Cardiovascular Diseases, +22 more
Locations
  • City of Hope Duarte, California, United States
  • City of Hope Orange County Lennar Foundation Cancer Center Irvine, California, United States
  • University of California San Francisco San Francisco, California, United States
  • Colorado Blood Cancer Institute Denver, Colorado, United States
View all 29 locations
View Trial Details
Recruiting

Actinium Therapy for Late-stage Aggressive Sarcomas

NCT07156565

Conditions
Advanced Soft Tissue Sarcoma, Disease Attributes, Neoplasms, +6 more
Locations
  • UCLA Los Angeles, California, United States
  • Mayo Clinic Rochester, Minnesota, United States
  • Memorial Sloane Kettering Cancer Center New York, United States
  • Case Western Cleveland, Ohio, United States
View Trial Details

Related conditions